Tülin Tatar

Tülin Tatar is a Postdoctoral Research Fellow at the Helin Group, Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Denmark. Her research focuses on epigenetic mechanisms in cancer biology and stem cell systems, with contact details including phone +4535326973 and email tulin.tatar@bric.ku.dk at Ole Maaløes Vej 5, 2200 København N.

Her research interests center on epigenetic regulation, specifically histone modifications (H3K27 methylation/acetylation), Polycomb repressive complexes (PRC2), and signaling pathways in cancer and pluripotent stem cells. She employs advanced genomic and biochemical techniques to investigate how epigenetic machinery controls cell fate decisions, tumor progression, and therapeutic responses, with emphasis on targets like MPP8, TAK1, and RIPK1.

Analysis of her publications reveals a cohesive research trajectory exploring epigenetic vulnerabilities in cancer and stem cell maintenance. Her work bridges fundamental chromatin biology with translational applications, particularly in immuno-oncology and regenerative medicine, demonstrating consistent contributions to high-impact journals including Nature Genetics and Molecular Cell.

No scientific awards were documented in the provided information.

While no student advising or grant details were specified, her collaborative publications indicate active participation in international research networks. Her work on TAK1 inhibition and PRC2 complex mechanics suggests ongoing exploration of targeted cancer therapies and epigenetic editing tools.

Dr. Tatar operates within the Helin Group at BRIC, a premier biomedical research hub at the University of Copenhagen specializing in epigenetic mechanisms of development and disease. The group leverages cutting-edge CRISPR-based editing, multi-omics approaches, and disease modeling to advance understanding of chromatin dynamics in health and pathology.